Dr Jing Lim joined Osteopore in November 2014 as a product development engineer before becoming product development manager in July 2015, chief technology officer in 2018, chief operating officer in 2022, and chief executive in July 2023. Dr Lim played a key role in the company reaching its key regulatory and quality milestones, including compliance with the European Union’s Medical Device Regulation. He also spearheaded a successful A$19m project with the National Dental Centre and A*Star.
In 2022, Dr Lim was recognised by Pharma Intelligence as one of 30 people to watch across the biopharma, med-tech and health-tech sectors in Vivo’s Rising Leaders.
He holds a PhD from Nanyang Technology University, Singapore.